GlaxoSmithKline Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
The Disclosure score includes 17 United Nations Sustainable Development Goals including: 'No Poverty', 'Responsible Production & Consumption' and 'Life on Land'. This analysis of GlaxoSmithKline Pharmaceuticals Ltd employs intelligence from across the internet and also from available disclosures by GlaxoSmithKline Pharmaceuticals Ltd. This article includes a Q&A table on GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 1.3, social score of 6.9 and governance score of 4.0.
4.1
Medium ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1725478325797)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
969 | Vertex Pharmaceuticals Inc | 4.2 | High |
969 | Zentalis Pharmaceuticals Inc | 4.2 | High |
989 | GlaxoSmithKline Pharmaceuticals Ltd | 4.1 | High |
989 | Advanz Pharma Corp Ltd | 4.1 | High |
989 | Abeona Therapeutics Inc | 4.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1725478325797)
Frequently Asked Questions
Does GlaxoSmithKline Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose current and historical energy intensity?
Does GlaxoSmithKline Pharmaceuticals Ltd report the average age of the workforce?
Does GlaxoSmithKline Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose its ethnicity pay gap?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose cybersecurity risks?
Does GlaxoSmithKline Pharmaceuticals Ltd offer flexible work?
Does GlaxoSmithKline Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Does GlaxoSmithKline Pharmaceuticals Ltd conduct supply chain audits?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does GlaxoSmithKline Pharmaceuticals Ltd conduct 360 degree staff reviews?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose the individual responsible for D&I?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose water use targets?
Does GlaxoSmithKline Pharmaceuticals Ltd have careers partnerships with academic institutions?
Did GlaxoSmithKline Pharmaceuticals Ltd have a product recall in the last two years?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose incidents of discrimination?
Does GlaxoSmithKline Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Has GlaxoSmithKline Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose parental leave metrics?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose the pay ratio of women to men?
Does GlaxoSmithKline Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does GlaxoSmithKline Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is GlaxoSmithKline Pharmaceuticals Ltd involved in embryonic stem cell research?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose its waste policy?
Does GlaxoSmithKline Pharmaceuticals Ltd report according to TCFD requirements?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose energy use targets?
Does GlaxoSmithKline Pharmaceuticals Ltd disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does GlaxoSmithKline Pharmaceuticals Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for GlaxoSmithKline Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, manufactures, and distributes pharmaceutical products and vaccines worldwide. It offers prescription and non-prescription drugs for asthma, infectious diseases, mental health, digestive conditions, and other diseases; and vaccines for various therapeutic areas, primarily cancer. The company also provides medicinal substances, such as antibiotics, endocrine products, and basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, and its salts and esters; glycosides and vegetable alkaloids; and chemically pure sugar. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is headquartered in Mumbai, India.